| 1. | I have reviewed this Annual Report on Form 10-KSB      of Sinofresh Healthcare, Inc.; |
|----|---------------------------------------------------------------------------------------|

| 2. | Based on my knowledge, this report does not      contain any untrue statement of a material fact or omit to state a      material fact necessary to make the statements made, in light of the      circumstances under which such statements were made, not misleading with      respect to the period covered by this report; |
|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3. | Based on my knowledge, the financial statements,      and other financial information included in this report, fairly present in      all material respects the financial condition, results of operations and      cash flows of the issuer as of, and for, the periods covered by this      report; |
|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 4. | I am responsible for establishing and      maintaining disclosure controls and procedures (as defined in Exchange Act      Rules 13a-15(e) and 15d-15(e)) and internal control over financial      reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for      the issuer and have: |
|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | a) | designed such disclosure controls and procedures,      or caused such disclosure controls and procedures to be designed under our      supervision, to ensure that material information relating to the issuer,      including its consolidated subsidiaries, is made known to us by others      within those entities, particularly during the period in which this report      is being prepared; |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | b) | designed such internal control over financial      reporting, or caused such internal control over financial reporting to be      designed under our supervision, to provide reasonable assurance regarding      the reliability of financial reporting and the preparation of financial      statements for external purposes in accordance with generally accepted      accounting principles; |
|--------|----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | c) | evaluated the effectiveness of the issuer’s      disclosure controls and procedures and presented in this report are      conclusions about the effectiveness of the disclosure controls and      procedures, as of the end of the period covered by this report based on      such evaluation; and |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | d) | disclosed in this report any change in the      issuer’s internal control over financial reporting that occurred during      the issuer’s fourth quarter that has materially affected or is reasonably      likely to materially affect, the issuer’s internal control over financial      reporting; |
|--------|----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 5. | I have disclosed, based on our most recent      evaluation of internal control over financial reporting, to the issuer’s      auditors and the audit committee of the issuer’s board of directors (or      persons performing the equivalent functions): |
|----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (a) | All significant deficiencies and material      weaknesses in the design or operation of internal control over financial      reporting which are reasonably likely to adversely affect the issuer’s      ability to record, process, summarize and report financial information;      and |
|--------|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | (b) | Any fraud, whether or not material, that involves      management or other employees who have a significant role in the issuer’s      internal control over financial reporting. |
|--------|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date: May 15, 2008 | By:    | /s/ Charles Fust                                                                                                   |
|--------------------|--------|--------------------------------------------------------------------------------------------------------------------|
|               |   | Charles Fust                                                                                                       |
|               |   | Chief Executive Officer(Principal Executive Officer)Acting Chief Financial Officer(Principal Financial    Officer) |